R R Bowsher|K M Verburg|D P Henry - JoVE Visualize

Showing results (81-90 of 156) with videos related to

Pageof 16

Sort By:

Hypertension (Dallas, Tex. : 1979)|March 1, 1989

Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeysK M Verburg, H D Kleinert, J R Kadam, et al.

Alimentary Pharmacology & Therapeutics|July 10, 2003

A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjectsJ L Goldstein, A J Kivitz, K M Verburg, et al.

Peptides|March 1, 1982

A new Met-enkephalin analogue suppresses plasma vasopressin in manR L Zerbe, D P Henry, G L Robertson

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1980

Mechanism of renal tubular secretion of norepinephrine in the rabbitR W Lappe, D P Henry, L R Willis

Life Sciences|January 9, 1984

Characterization of norepinephrine binding to plasma proteins of the dog and the rabbitJ W VanHuysse, D P Henry, L R Willis

The American Journal of Medicine|February 1, 1983

Vasopressin response to orthostatic hypotension. Etiologic and clinical implicationsR L Zerbe, D P Henry, G L Robertson

Canadian Journal of Physiology and Pharmacology|August 1, 1982

Contribution of renal sympathetic nerves to the urinary excretion of norepinephrineR W Lappe, D P Henry, L R Willis

Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982

The role of the sympathetic nervous system in the modulation of sodium excretionM H Weinberger, F C Luft, D P Henry

Clinical Pharmacology and Therapeutics|October 1, 1995

[Lys(B28), Pro(B29)]-human insulin: effect of injection time on postprandial glycemiaD C Howey, R R Bowsher, R L Brunelle, et al.

Diabetes Care|May 1, 1992

Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experienceJ A Galloway, S A Hooper, C T Spradlin, et al.

Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:

Pageof 16

Hypertension (Dallas, Tex. : 1979)|March 1, 1989

Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeysK M Verburg, H D Kleinert, J R Kadam, et al.

Alimentary Pharmacology & Therapeutics|July 10, 2003

A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjectsJ L Goldstein, A J Kivitz, K M Verburg, et al.

Peptides|March 1, 1982

A new Met-enkephalin analogue suppresses plasma vasopressin in manR L Zerbe, D P Henry, G L Robertson

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1980

Mechanism of renal tubular secretion of norepinephrine in the rabbitR W Lappe, D P Henry, L R Willis

Life Sciences|January 9, 1984

Characterization of norepinephrine binding to plasma proteins of the dog and the rabbitJ W VanHuysse, D P Henry, L R Willis

The American Journal of Medicine|February 1, 1983

Vasopressin response to orthostatic hypotension. Etiologic and clinical implicationsR L Zerbe, D P Henry, G L Robertson

Canadian Journal of Physiology and Pharmacology|August 1, 1982

Contribution of renal sympathetic nerves to the urinary excretion of norepinephrineR W Lappe, D P Henry, L R Willis

Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982

The role of the sympathetic nervous system in the modulation of sodium excretionM H Weinberger, F C Luft, D P Henry

Clinical Pharmacology and Therapeutics|October 1, 1995

[Lys(B28), Pro(B29)]-human insulin: effect of injection time on postprandial glycemiaD C Howey, R R Bowsher, R L Brunelle, et al.

Diabetes Care|May 1, 1992

Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experienceJ A Galloway, S A Hooper, C T Spradlin, et al.

Pageof 16